Literature DB >> 925693

Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.

D Davidson, I A Pullar, C Mawdsley, N Kinloch, C M Yates.   

Abstract

The concentrations of homovanillic acid (HVA), 5-hydroxyindolylacetic acid (5-HIAA), and 4-hydroxy, 3-methoxyphenylethylene glycol (MHPG) were estimated in the lumbar cerebrospinal fluid (CSF) of control subjects and in some patients who probably, and others who definitely, suffered from multiple sclerosis (MS). In the control group, the concentration of HVA was lower in people who underwent lumbar puncture having fasted and been recumbent for 12 hours before the procedure than in those from whom CSF was obtained under non-standardised conditions. These studies demonstrate that a standardised procedure for lumbar puncture is required in order to obtain meaningful results. In patients suffering from MS the CSF 5-HIAA concentrations were significantly lower than in comparable controls but the HVA concentrations did not differ. There was no relationship between metabolite concentrations, site of lesion, the duration of the disease, gamma-globulin levels nor the occurrence of relapse within the previous month.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925693      PMCID: PMC492827          DOI: 10.1136/jnnp.40.8.741

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases.

Authors:  B Johannsson; B E Roos
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

Review 2.  Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.

Authors:  E Garelis; S N Young; S Lal; T L Sourkes
Journal:  Brain Res       Date:  1974-10-11       Impact factor: 3.252

3.  Determination of 3-methoxy-4-hydroxyphenylethylene glycol, a noradrenaline metabolite, in cerebrospinal fluid and urine.

Authors:  R O'Keeffe; B W Brooksbank
Journal:  Clin Chem       Date:  1973-09       Impact factor: 8.327

4.  Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis.

Authors:  V Sonninen; P Riekkinen; U K Rinne
Journal:  Neurology       Date:  1973-07       Impact factor: 9.910

5.  Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness.

Authors:  R M Post; J Kotin; F K Goodwin; E K Gordon
Journal:  Am J Psychiatry       Date:  1973-01       Impact factor: 18.112

6.  Concentration gradients of monoamine metabolites in human cerebrospinal fluid.

Authors:  R Sjöström; J Ekstedt; E Anggård
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

7.  Glycol metabolites of noradrenaline in brain tissue.

Authors:  D F Sharman
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

8.  Phenolic acid concentrations in the lumbar cerebrospinal fluid of Parkinsonian patients treated with L-dopa.

Authors:  I A Pullar; J M Weddell; R Ahmed; F J Gillingham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-12       Impact factor: 10.154

9.  Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis.

Authors:  L E Claveria; G Curzon; M J Harrison; B D Kantamaneni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-06       Impact factor: 10.154

  9 in total
  6 in total

1.  CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.

Authors:  D L Davidson; C M Yates; C Mawdsley; I A Pullar; H Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-12       Impact factor: 10.154

2.  Altered serotonin uptake kinetics in multiple sclerosis.

Authors:  M Markianos; C Sfagos
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

3.  Action of cyproheptadine in spastic paraparetic patients.

Authors:  H Barbeau; C L Richards; P J Bédard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

4.  Amine metabolites in ventricular cerebrospinal fluid in coma.

Authors:  C M Yates; S A Tsementzis; H Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-10       Impact factor: 10.154

Review 5.  Closed-Loop Implantable Therapeutic Neuromodulation Systems Based on Neurochemical Monitoring.

Authors:  Khalid B Mirza; Caroline T Golden; Konstantin Nikolic; Christofer Toumazou
Journal:  Front Neurosci       Date:  2019-08-20       Impact factor: 4.677

Review 6.  Immunologic aspects of migraine: A review of literature.

Authors:  Mehrnaz Salahi; Sina Parsa; Delaram Nourmohammadi; Zahra Razmkhah; Omid Salimi; Mohammadreza Rahmani; Saeid Zivary; Monireh Askarzadeh; Mohammad Amin Tapak; Ali Vaezi; Hamidreza Sadeghsalehi; Shirin Yaghoobpoor; Mehran Mottahedi; Setareh Garousi; Niloofar Deravi
Journal:  Front Neurol       Date:  2022-09-28       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.